Therapeutic apheresis and plasma exchange with our all-in-one platform
The LIFE 21® – TheraSorb® therapeutic apheresis platform with its specific adsorbers allows the selective removal of pathogenic substances such as immunoglobulins1, LDL cholesterol, and lipoprotein (a)2 from the patient’s plasma. LDL and lipoprotein (a) are removed simultaneously using a single type of adsorber.
Since no substitution fluid is required, the treatment is usually very well tolerated.3 Therapeutic plasma exchange (TPE)4 enables the non-selective removal of pathogenic substances. TheraSorb® products can be helpful for the treatment of a variety of different indications.5,6,7
For complete regulatory notes click here.
Since no substitution fluid is required, the treatment is usually very well tolerated.3 Therapeutic plasma exchange (TPE)4 enables the non-selective removal of pathogenic substances. TheraSorb® products can be helpful for the treatment of a variety of different indications.5,6,7
For complete regulatory notes click here.
